Search - tctmd.com

Displaying 561 - 580 of 726

Sort: Relevancy | Date

News Daily News

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

L.A. McKeown

February 25, 2015

Presentation CADECI 2015

Carotid Artery Stenting: Risk Stratification and Patient Selection

Presenter: Hugo Londero

February 20, 2015

Presentation CADECI 2015

Subclinical CV Disease Heart – Brain Integration

Presenter: CADECI 2015

February 19, 2015

Presentation CADECI 2015

Sistema de protección proximal en angioplastía carotídea_

Presenter: Juan Carlos Parodi

February 19, 2015

Presentation CADECI 2015

The future of Drug-Eluting Stent

Presenter: Renu Virmani

February 18, 2015

Presentation CADECI 2015

The evolution of catheter cryoablationfrom focal to cryoballoon technology

Presenter: Marc Dubuc

February 18, 2015

News Daily News

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

L.A. McKeown

January 29, 2015

News Daily News

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Yael L. Maxwell

January 28, 2015

Presentation

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Presenter: Bernard Chevalier

January 12, 2015

Presentation

Hybrid Revascularization for Multivessel CAD

Presenter: M Gasior

November 25, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Long-Term Better than Short-Term Prasugrel After PES Stenting

November 15, 2014

News Conference News AHA 2014

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

Yael L. Maxwell

November 15, 2014

Presentation

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

Presenter: Antonio Colombo

November 10, 2014

News Daily News

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

L.A. McKeown

November 06, 2014

News Daily News

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

L.A. McKeown

November 06, 2014

Advertisement

ZEUS Publicado: Los SLZ + Tratamiento Antiplaquetario Doble Personalizado Superan a los SMD en Candidatos SLF ‘Inciertos’

Carotid Artery Stenting: Risk Stratification and Patient Selection

Subclinical CV Disease Heart – Brain Integration

Sistema de protección proximal en angioplastía carotídea_

The future of Drug-Eluting Stent

The evolution of catheter cryoablationfrom focal to cryoballoon technology

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

含可生物降解聚合物的 DES 可安全使用、耐用长达 5 年

DES With Biodegradable Polymer Safe, Durable Through 5 Years

TE-PROVE: Estudio Europeo Post-Aprobación de SLP Confirma la Seguridad en Pacientes No Seleccionados

Five-Year Clinical Outcome of the Nobori DES in the Treatment of Patients With CAD

Hybrid Revascularization for Multivessel CAD

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Long-Term Better than Short-Term Prasugrel After PES Stenting

ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders

SECURITY: Second-Generation DES Implantation Followed by 6- vs 12-Month DAPT

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content